XML 59 R139.htm IDEA: XBRL DOCUMENT v2.4.0.6
Schedule I Condensed Financial Information of Registrant Institutional Financial Markets, Inc. (Parent Company) Statement of Cash Flows (Detail) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Operating activities      
Net income / (loss) $ (968) $ (9,388) $ 7,595
Adjustments to reconcile net income / (loss) to net cash used in operating activities:      
Gain on repurchase from debt (86) (33) (2,555)
Increase/ (decrease) in accounts payable and other liabilities (1,355) (2,720) 25
Change in deferred income taxes (897) (1,389) (828)
Net cash provided by (used in) operating activities 14,748 (6,299) (34,815)
Financing activities      
Repurchase of debt (16,270) (7,960) (24,283)
Cash used to net share settle equity awards (199) (72) (166)
Dividends paid to stockholders (953) (2,115) (1,043)
Net cash provided by (used in) financing activities (27,717) (12,796) (17,069)
Net increase (decrease) in cash and cash equivalents (3,721) (25,725) (25,746)
Parent [Member]
      
Operating activities      
Net income / (loss) (968) (9,388) 7,595
Adjustments to reconcile net income / (loss) to net cash used in operating activities:      
Equity in undistributed earnings / (loss) of IFMI, LLC (2,666) 5,480 (12,417)
Distributions from IFMI, LLC 15,943 8,346 13,233
Gain on repurchase from debt (3) (33) (923)
Amortization of discount of debt 189 429 88
Change in current federal income receivable 246 12 (286)
Increase/ (decrease) in accounts payable and other liabilities (330) 9 (84)
Change in deferred income taxes (826) (1,708) (509)
Net cash provided by (used in) operating activities 11,585 3,147 6,697
Financing activities      
Repurchase of debt (10,357) (984) (5,544)
Cash used to net share settle equity awards (135) (48) (110)
Dividends paid to stockholders (953) (2,115) (1,043)
Net cash provided by (used in) financing activities (11,445) (3,147) (6,697)
Net increase (decrease) in cash and cash equivalents 140    
Cash and cash equivalents, beginning of period         
Cash and cash equivalents, end of period $ 140